QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

FDMT

QT674D Molecular Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
9.66
+0.24+2.55%
OverviewShort InterestFilings
FDMTQT674D Molecular Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
9.66+2.55%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own35.98%
Shs Outstand52.28M
Perf Week9.28%
Market Cap492.44MForward P/E-EPS next Y-3.72Insider Trans0.00%Shs Float-Perf Month15.00%
Enterprise Value440.49MPEG-EPS next Q-0.97Inst Own-Short Float-Perf Quarter7.57%
Income-123553776.00P/S5.58EPS this Y-Inst Trans-Short Ratio-Perf Half Y-16.15%
Sales88.24MP/B1.42EPS next Y4.25%ROA-31.37%Short Interest-Perf YTD28.80%
Book/sh-P/C-EPS next 5Y-ROE-36.83%52W High12.34 -21.72%Perf Year132.77%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-37.80%52W Low3.68 162.50%Perf 3Y-
Dividend Est.-EV/EBITDA-2.70Sales past 3/5Y-Gross Margin-12.45%Volatility5.72% 5.05%Perf 5Y-
Dividend TTM-EV/Sales4.99EPS Y/Y TTM-Oper. Margin-203.47%ATR (14)0.72Perf 10Y-
Dividend Ex-Date-Quick Ratio9.34Sales Y/Y TTM-Profit Margin-182.34%RSI (14)54.47Recom2.00
Dividend Gr. 3/5Y-Current Ratio9.34EPS Q/Q-17.44%SMA206.08%Beta1.39Target Price33.00
Payout0.00%Debt/Eq0.05Sales Q/Q-SMA502.44%Rel Volume1.20Prev Close9.42
Employees227LT Debt/Eq-EarningsAug 10SMA2004.58%Avg Volume745.25KPrice9.66
IPO DateDec 11, 2020Option/ShortYes / YesEPS/Sales Surpr.-4.12% 0.00%Net Debt/EBITDA0.32Volume892,221Change2.55%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedGoldman SachsBuy$38 → $33
Nov-11-25ReiteratedBarclaysOverweight$45 → $33
Oct-31-25ReiteratedLeerink PartnersOutperform$17
Oct-21-25ReiteratedRBC CapitalOutperform$40 → $26
Sep-23-24DowngradeCantor FitzgeraldOverweight → Neutral
Sep-19-24ReiteratedBMO CapitalOutperform$63 → $40
Sep-19-24ReiteratedLoop Capital Markets$39
Apr-15-24ReiteratedBarclays$45
Apr-15-24ReiteratedRBC CapitalOutperform$40
Apr-01-24ReiteratedJefferiesBuy$58
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$10.30$9.01$7.71$6.42$5.13● Close Price0.00K18.21K36.42K54.63K72.84KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kirn DavidSee RemarksJun 01 '26Sale10.021,92219,2581,057,231Jun 02 12:00 AM
Gupta AshooVP, Finance and ControllerMar 20 '26Sale8.613903,35846,914Mar 24 12:00 AM
Gupta AshooVP, Finance and ControllerMar 20 '26Option Exercise0.002,172047,224Mar 24 12:00 AM
Gupta AshooVP, Finance and ControllerDec 20 '25Option Exercise0.002,172046,528Dec 23 12:00 AM
Gupta AshooVP, Finance and ControllerDec 20 '25Sale8.683893,37746,218Dec 23 12:00 AM
Bizily ScottChief Legal OfficerDec 16 '25Option Exercise4.143,27013,53873,595Dec 19 12:00 AM
Bizily ScottChief Legal OfficerDec 16 '25Sale10.901,63517,8223,594Dec 19 12:00 AM
THEUER CHARLESDirectorDec 12 '25Option Exercise1.1418,66621,28041,684Dec 16 12:00 AM
Bizily ScottChief Legal OfficerNov 17 '25Option Exercise4.143,27013,53875,230Nov 19 12:00 AM
Bizily ScottChief Legal OfficerNov 17 '25Sale10.591,63517,3153,594Nov 19 12:00 AM
Bizily ScottChief Legal OfficerOct 24 '25Option Exercise6.492,16814,0709,295Oct 27 12:00 AM
Bizily ScottChief Legal OfficerOct 24 '25Sale12.002,67832,1363,594Oct 27 12:00 AM
Bizily ScottChief Legal OfficerOct 16 '25Option Exercise4.143,27013,53876,865Oct 20 12:00 AM
Bizily ScottChief Legal OfficerOct 16 '25Sale10.171,63516,6285,188Oct 20 12:00 AM
Bizily ScottChief Legal OfficerOct 09 '25Sale10.002,40824,0805,188Oct 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR